![Placeholder: With immune checkpoint inhibitor therapy: Antibody binds to PD-1 or PD-L1 receptor Blocks interaction between PD-1 and PD-L1 Remove brakes on T cell activation Result: T cell fully activates upon tumor antigen recognition T cell divides and proliferates T cell releases cytokines and cytotoxic granules Tumor cell killed by immune response Unleashes anti-tumor immunity)](https://img.stablecog.com/insecure/64w/aHR0cHM6Ly9iLnN0YWJsZWNvZy5jb20vNTU3N2ExYTUtZDE5Ny00NWFmLWI1Y2ItZjA0NjNjMmI4MzRlLmpwZWc.webp)
![With immune checkpoint inhibitor therapy: Antibody binds to PD-1 or PD-L1 receptor Blocks interaction between PD-1 and PD-L1 Remove brakes on T cell activation Result: T cell fully activates upon tumor antigen recognition T cell divides and proliferates T cell releases cytokines and cytotoxic granules Tumor cell killed by immune response Unleashes anti-tumor immunity)](https://img.stablecog.com/insecure/1920w/aHR0cHM6Ly9iLnN0YWJsZWNvZy5jb20vNTU3N2ExYTUtZDE5Ny00NWFmLWI1Y2ItZjA0NjNjMmI4MzRlLmpwZWc.webp)
@x6zsa0atjlfd
Prompt
With immune checkpoint inhibitor therapy: Antibody binds to PD-1 or PD-L1 receptor Blocks interaction between PD-1 and PD-L1 Remove brakes on T cell activation Result: T cell fully activates upon tumor antigen recognition T cell divides and proliferates T cell releases cytokines and cytotoxic granules Tumor cell killed by immune response Unleashes anti-tumor immunity)
8 months ago
Model
Kandinsky 2.2
Guidance Scale
7
Dimensions
3328 × 4992